InsiderTrades.com logo

BBIO Insider Trading

Insider Ownership Percentage: 18.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $461,917,861.47

BridgeBio Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at BridgeBio Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BridgeBio Pharma Share Price & Price History

Current Price: $68.54
Price Change: ▼ Price Decrease of -1.53 (-2.18%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for BBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BridgeBio Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/12/2026Neil KumarCEOSell40,000$68.73$2,749,200.00655,686View SEC Filing Icon  
3/4/2026Andrea EllisDirectorSell64,921$64.87$4,211,425.2718,589View SEC Filing Icon  
2/19/2026Neil KumarCEOSell28,053$71.39$2,002,703.67234,451View SEC Filing Icon  
2/17/2026Maricel ApuliCAOSell510$74.31$37,898.10123,945View SEC Filing Icon  
2/17/2026Randal W. ScottDirectorSell10,000$75.46$754,600.0011,589View SEC Filing Icon  
2/17/2026Thomas TrimarchiCFOSell13,600$74.72$1,016,192.00336,585View SEC Filing Icon  
2/10/2026Neil KumarCEOSell40,000$71.94$2,877,600.00695,686View SEC Filing Icon  
1/8/2026Neil KumarCEOSell40,000$73.97$2,958,800.00735,686View SEC Filing Icon  
12/15/2025Neil KumarCEOSell30,011$74.64$2,240,021.04228,776View SEC Filing Icon  
12/8/2025Maricel ApuliCAOSell2,000$74.26$148,520.00130,297View SEC Filing Icon  
12/4/2025Neil KumarCEOSell40,000$74.40$2,976,000.00775,686View SEC Filing Icon  
11/20/2025Neil KumarCEOSell26,156$65.84$1,722,111.04228,776View SEC Filing Icon  
11/18/2025Andrew LoDirectorSell55,000$65.69$3,612,950.0050,583View SEC Filing Icon  
11/17/2025Andrew LoDirectorSell40,599$66.67$2,706,735.3314,089View SEC Filing Icon  
11/17/2025Randal W. ScottDirectorSell10,000$66.65$666,500.0011,589View SEC Filing Icon  
11/17/2025Thomas TrimarchiCFOSell16,934$66.46$1,125,433.64382,830View SEC Filing Icon  
11/12/2025Hannah ValantineDirectorSell25,484$66.07$1,683,727.887,465View SEC Filing Icon  
11/6/2025Neil KumarCEOSell40,000$63.15$2,526,000.00815,686View SEC Filing Icon  
11/6/2025Ronald J. DanielsDirectorSell61,031$63.72$3,888,895.3216,991View SEC Filing Icon  
10/29/2025Frank McCormickDirectorSell198,359$66.58$13,206,742.22679,979View SEC Filing Icon  
10/27/2025Frank McCormickDirectorSell1,641$65.00$106,665.00878,338View SEC Filing Icon  
10/8/2025Neil KumarCEOSell40,000$54.78$2,191,200.00855,686View SEC Filing Icon  
9/5/2025Frank McCormickDirectorSell74,000$53.16$3,933,840.0083,275View SEC Filing Icon  
9/4/2025Neil KumarCEOSell40,000$51.34$2,053,600.00895,686View SEC Filing Icon  
8/21/2025Thomas TrimarchiCFOSell42,237$49.48$2,089,886.76421,081View SEC Filing Icon  
8/20/2025Neil KumarCEOSell26,156$48.82$1,276,935.92223,090View SEC Filing Icon  
8/18/2025Thomas TrimarchiCFOSell17,353$50.23$871,641.19463,318View SEC Filing Icon  
8/11/2025Charles J HomcyDirectorSell50,000$48.00$2,400,000.00916,674View SEC Filing Icon  
8/8/2025Charles J HomcyDirectorSell250,000$46.05$11,512,500.00966,674View SEC Filing Icon  
8/7/2025Maricel ApuliCAOSell1,000$45.44$45,440.00141,859View SEC Filing Icon  
8/7/2025Neil KumarCEOSell40,000$45.45$1,818,000.00935,686View SEC Filing Icon  
8/5/2025Andrea EllisDirectorSell17,167$49.00$841,183.0018,589View SEC Filing Icon  
7/1/2025Neil KumarCEOSell40,000$42.54$1,701,600.00975,686View SEC Filing Icon  
6/27/2025Global Investors Lp VikingMajor ShareholderSell3,500,000$44.00$154,000,000.0018,555,375View SEC Filing Icon  
6/26/2025Hannah ValantineDirectorSell2,418$44.05$106,512.907,465View SEC Filing Icon  
6/26/2025Hannah ValantineDirectorSell2,289$44.05$100,830.45398View SEC Filing Icon  
6/24/2025Frank McCormickDirectorSell100,000$44.23$4,423,000.00879,979View SEC Filing Icon  
6/10/2025Hannah ValantineDirectorSell4,292$40.00$171,680.001,764View SEC Filing Icon  
5/20/2025Neil KumarCEOSell75,000$33.40$2,505,000.004,798,447View SEC Filing Icon  
5/19/2025Neil KumarCEOSell26,156$33.33$871,779.48217,404View SEC Filing Icon  
5/12/2025Genetic Disorder L.P. KkrMajor ShareholderSell6,000,000$34.20$205,200,000.0013,260,971View SEC Filing Icon  
5/2/2025Andrew LoDirectorSell100,000$38.50$3,850,000.00105,583View SEC Filing Icon  
5/2/2025Maricel ApuliCAOSell1,026$38.51$39,511.26147,639View SEC Filing Icon  
4/22/2025Neil KumarCEOSell75,000$34.11$2,558,250.004,873,447View SEC Filing Icon  
4/14/2025Andrea EllisDirectorSell10,000$35.00$350,000.0012,000View SEC Filing Icon  
4/1/2025Andrea EllisDirectorSell30,000$34.05$1,021,500.0012,000View SEC Filing Icon  
3/25/2025Neil KumarCEOSell75,000$36.87$2,765,250.004,948,447View SEC Filing Icon  
3/5/2025Genetic Disorder L.P. KkrMajor ShareholderSell6,000,000$32.96$197,760,000.0019,260,971View SEC Filing Icon  
2/25/2025Brian C. StephensonCFOSell8,500$33.19$282,115.00102,464View SEC Filing Icon  
2/25/2025Neil KumarCEOSell75,000$33.57$2,517,750.005,023,447View SEC Filing Icon  
2/19/2025Brian C. StephensonCFOSell4,148$36.16$149,991.68102,464View SEC Filing Icon  
2/19/2025Neil KumarCEOSell31,543$36.14$1,139,964.02211,718View SEC Filing Icon  
1/31/2025Global Investors Lp VikingMajor ShareholderSell3,065,616$34.90$106,989,998.4022,055,375View SEC Filing Icon  
1/28/2025Brian C. StephensonCFOSell68,000$36.29$2,467,720.0093,758View SEC Filing Icon  
1/28/2025Neil KumarCEOSell326,932$36.29$11,864,362.285,371,515View SEC Filing Icon  
11/19/2024Brian C. StephensonCFOSell4,156$22.41$93,135.9693,758View SEC Filing Icon  
11/19/2024Neil KumarCEOSell27,389$22.41$613,787.494,897,443View SEC Filing Icon  
9/13/2024Genetic Disorder L.P. KkrMajor ShareholderSell5,800,000$25.75$149,350,000.0025,260,971View SEC Filing Icon  
8/19/2024Brian C. StephensonCFOSell4,155$24.69$102,586.9585,192View SEC Filing Icon  
8/19/2024Neil KumarCEOSell27,389$24.69$676,234.414,897,443View SEC Filing Icon  
6/3/2024Randal W. ScottDirectorSell1,000$28.84$28,840.005,500View SEC Filing Icon  
3/1/2024Randal W. ScottDirectorSell2,500$34.00$85,000.006,500View SEC Filing Icon  
1/16/2024Hannah ValantineDirectorSell2,915$37.97$110,682.551,764View SEC Filing Icon  
12/26/2023Frank McCormickDirectorSell100,000$42.06$4,206,000.00627,689View SEC Filing Icon  
12/18/2023Randal W. ScottDirectorSell2,000$40.00$80,000.009,000View SEC Filing Icon  
8/17/2023Brian C. StephensonCFOSell22,683$28.59$648,506.9736,710View SEC Filing Icon  
8/17/2023Neil KumarCEOSell51,552$28.59$1,473,871.684,813,197View SEC Filing Icon  
7/18/2023Global Investors Lp VikingMajor ShareholderSell1,500,000$35.00$52,500,000.0025,120,991View SEC Filing Icon  
5/17/2023Brian C. StephensonCFOSell24,424$14.01$342,180.2436,408View SEC Filing Icon  
5/17/2023Neil KumarCEOSell51,552$14.01$722,243.524,813,197View SEC Filing Icon  
4/5/2023Brian C. StephensonCFOSell55,500$15.45$857,475.00101,337View SEC Filing Icon  
4/5/2023Neil KumarCEOSell120,000$15.46$1,855,200.001,132,722View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BridgeBio Pharma (NASDAQ:BBIO)

99.85% of BridgeBio Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BBIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BridgeBio Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026Hsbc Holdings PLC13,665$1.05M0.0%N/A0.007%Search for SEC Filing on Google Icon
3/17/2026Rockefeller Capital Management L.P.38,429$2.94M0.0%+189.8%0.020%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC16,436$1.26M0.0%-4.7%0.008%Search for SEC Filing on Google Icon
2/19/2026Compound Planning Inc.2,723$0.21M0.0%-82.1%0.001%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.4,831,305$369.55M0.1%+23.0%2.507%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC16,436$1.26M0.0%-4.7%0.009%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp54,495$4.11M0.0%+8.9%0.028%Search for SEC Filing on Google Icon
2/18/2026ADAR1 Capital Management LLC213,414$16.32M1.2%-36.9%0.111%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd13,169$1.01M0.0%+162.4%0.007%Search for SEC Filing on Google Icon
2/18/2026VARCOV Co.4,447$0.34M0.1%N/A0.002%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC638,883$48.87M0.2%+377.4%0.332%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC9,093$0.70M0.2%-18.9%0.005%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP2,348,731$179.65M0.1%+130.4%1.219%Search for SEC Filing on Google Icon
2/18/2026SummitTX Capital L.P.35,785$2.74M0.1%-3.8%0.019%Search for SEC Filing on Google Icon
2/18/2026Sphera Funds Management LTD.107,746$8.24M1.6%-36.9%0.056%Search for SEC Filing on Google Icon
2/18/2026Odyssean LLC10,027$0.77M0.6%N/A0.005%Search for SEC Filing on Google Icon
2/18/2026Opaleye Management Inc.18,319$1.40M0.2%N/A0.010%Search for SEC Filing on Google Icon
2/18/2026Man Group plc20,004$1.53M0.0%-98.5%0.010%Search for SEC Filing on Google Icon
2/18/2026Ishara Investments LP36,000$2.75M3.2%N/A0.019%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC11,000,457$841.35M0.4%+25.8%5.708%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP15,574$1.19M0.0%+127.6%0.008%Search for SEC Filing on Google Icon
2/18/2026Cinctive Capital Management LP70,175$5.37M0.3%-26.7%0.036%Search for SEC Filing on Google Icon
2/18/2026Cormorant Asset Management LP1,200,000$91.79M4.2%-14.3%0.623%Search for SEC Filing on Google Icon
2/18/2026Boone Capital Management LLC184,963$14.15M4.7%-59.8%0.096%Search for SEC Filing on Google Icon
2/17/2026Freestone Grove Partners LP125,201$9.58M0.1%+33.9%0.065%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC34,734$2.66M0.0%-13.1%0.018%Search for SEC Filing on Google Icon
2/17/2026Viking Global Investors LP14,393,934$1.10B2.9%-9.9%7.469%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC213,414$16.32M1.2%-36.9%0.111%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC134,517$10.29M0.0%+36.1%0.070%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC10,571$0.81M0.2%N/A0.005%Search for SEC Filing on Google Icon
2/17/2026EFG International AG88,255$6.75M0.1%N/A0.046%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers72,737$5.56M0.0%-2.7%0.038%Search for SEC Filing on Google Icon
2/17/2026Kovack Advisors Inc.10,300$0.79M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/17/2026Farallon Capital Management LLC8,998,463$688.29M3.2%+9.8%4.669%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD3,828,746$292.86M0.0%+144.2%1.987%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP103,500$7.92M0.4%+21.8%0.054%Search for SEC Filing on Google Icon
2/17/2026GeoWealth Management LLC6,299$0.48M0.0%-67.2%0.003%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.252,145$19.29M0.0%-3.0%0.131%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.508,134$38.87M0.1%-46.2%0.264%Search for SEC Filing on Google Icon
2/17/2026Granahan Investment Management LLC101,805$7.79M0.3%-36.9%0.053%Search for SEC Filing on Google Icon
2/17/2026Kemnay Advisory Services Inc.539$41K0.0%N/A0.000%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors3,714$0.28M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/17/2026Summit Partners Public Asset Management LLC813,794$62.25M1.3%+0.9%0.422%Search for SEC Filing on Google Icon
2/17/2026Artisan Partners Limited Partnership279,067$21.35M0.0%-15.8%0.145%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC204,096$15.61M0.1%+3.4%0.106%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP125,302$9.58M0.1%+311.8%0.065%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada145,875$11.16M0.0%-76.6%0.076%Search for SEC Filing on Google Icon
2/17/2026Brooklands Fund Management Ltd2,750,000$210.35M27.5%N/A1.427%Search for SEC Filing on Google Icon
2/17/2026University of Texas Texas AM Investment Management Co.8,427$0.65M0.1%-27.1%0.004%Search for SEC Filing on Google Icon
2/16/2026Okabena Investment Services Inc.10,871$0.83M0.2%-30.8%0.006%Search for SEC Filing on Google Icon
2/16/2026Sofinnova Investments Inc.720,448$55.11M2.2%-13.4%0.374%Search for SEC Filing on Google Icon
2/16/2026Truvestments Capital LLC1,155$88K0.0%+112.7%0.001%Search for SEC Filing on Google Icon
2/16/2026Vanguard Personalized Indexing Management LLC17,239$1.32M0.0%+2.6%0.009%Search for SEC Filing on Google Icon
2/16/2026Panagora Asset Management Inc.738,843$56.51M0.2%+1.3%0.383%Search for SEC Filing on Google Icon
2/16/2026Public Employees Retirement Association of Colorado15,637$1.20M0.0%+53.4%0.008%Search for SEC Filing on Google Icon
2/16/2026MML Investors Services LLC4,953$0.38M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC4,327$0.33M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/16/2026Nicholas Investment Partners LP284,682$21.78M1.6%+4.8%0.148%Search for SEC Filing on Google Icon
2/16/2026First Turn Management LLC595,473$45.55M5.2%+1.0%0.309%Search for SEC Filing on Google Icon
2/16/2026Frazier Life Sciences Management L.P.3,545,557$271.20M7.3%-7.8%1.840%Search for SEC Filing on Google Icon
2/16/2026Eventide Asset Management LLC362,130$27.70M0.4%-38.0%0.188%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP11,255$0.86M0.0%+39.8%0.006%Search for SEC Filing on Google Icon
2/13/2026Prosight Management LP30,000$2.30M0.5%-88.7%0.016%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC3,075$0.24M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/13/2026FORA Capital LLC18,035$1.40M0.2%+62.2%0.009%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP74,686$5.71M0.0%-26.2%0.039%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 1,975,315$151.01M0.1%+3.2%1.025%Search for SEC Filing on Google Icon
2/13/2026Southport Management L.L.C.7,500$0.57M2.0%-25.0%0.004%Search for SEC Filing on Google Icon
2/13/2026Inspire Advisors LLC6,308$0.48M0.0%-49.7%0.003%Search for SEC Filing on Google Icon
2/13/2026Affinity Asset Advisors LLC320,000$24.48M1.4%+392.3%0.166%Search for SEC Filing on Google Icon
2/13/2026Bridgewater Associates LP43,172$3.30M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/13/2026Quarry LP3,600$0.28M0.1%-42.4%0.002%Search for SEC Filing on Google Icon
2/13/2026Smartleaf Asset Management LLC739$56K0.0%+63.1%0.000%Search for SEC Filing on Google Icon
2/13/2026Exome Asset Management LLC80,723$6.18M3.0%-39.3%0.042%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC80,018$6.12M0.0%-47.4%0.042%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP281,686$21.55M0.0%+14.7%0.146%Search for SEC Filing on Google Icon
2/13/2026Itau Unibanco Holding S.A.819$63K0.0%-44.3%0.000%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.1,964,419$150.26M0.0%+2.0%1.019%Search for SEC Filing on Google Icon
2/13/2026Police & Firemen s Retirement System of New Jersey42,788$3.27M0.0%-1.9%0.022%Search for SEC Filing on Google Icon
2/13/2026Ieq Capital LLC66,520$5.09M0.0%-8.9%0.035%Search for SEC Filing on Google Icon
2/13/2026Vontobel Holding Ltd.19,062$1.46M0.0%+82.6%0.010%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC451,016$34.50M0.0%-12.1%0.234%Search for SEC Filing on Google Icon
2/13/2026Y Intercept Hong Kong Ltd54,110$4.14M0.1%+288.4%0.028%Search for SEC Filing on Google Icon
2/13/2026Platinum Investment Management Ltd.47,756$3.65M0.8%-23.3%0.025%Search for SEC Filing on Google Icon
2/13/2026Rhenman & Partners Asset Management AB81,600$6.24M0.6%N/A0.042%Search for SEC Filing on Google Icon
2/13/2026Castleark Management LLC114,017$8.72M0.3%-7.8%0.059%Search for SEC Filing on Google Icon
2/12/2026Advisors Asset Management Inc.12,522$0.96M0.0%-1.1%0.006%Search for SEC Filing on Google Icon
2/12/2026Federation des caisses Desjardins du Quebec9,529$0.73M0.0%+17.5%0.005%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP41,099$3.14M0.0%-33.0%0.021%Search for SEC Filing on Google Icon
2/12/2026Brooklyn Investment Group4,172$0.32M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/12/2026Orion Porfolio Solutions LLC5,634$0.43M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC87,610$6.70M0.0%-4.3%0.045%Search for SEC Filing on Google Icon
2/12/2026Cibc World Markets Corp10,500$0.80M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/12/2026Commonwealth Equity Services LLC5,179$0.40M0.0%+4.9%0.003%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP382,569$29.25M0.0%+460.5%0.199%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.586,795$44.88M0.1%+38.2%0.304%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc1,263,484$96.64M0.2%-6.5%0.656%Search for SEC Filing on Google Icon
2/12/2026Informed Momentum Co LLC95,206$7.28M0.8%-2.0%0.049%Search for SEC Filing on Google Icon
2/12/2026Skandinaviska Enskilda Banken AB publ 237,791$18.19M0.1%+59.7%0.123%Search for SEC Filing on Google Icon
2/12/2026CIBC Private Wealth Group LLC9,061$0.69M0.0%+16.8%0.005%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BridgeBio Pharma logo
BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers. Its products in development programs include AG10, a next-generation oral small molecule near-complete TTR stabilizer that is in Phase 3 clinical trial for the treatment of TTR amyloidosis, or transthyretin amyloid cardiomyopathy (ATTR-CM); low-dose infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor, which is in Phase 3 double-blinded, placebo-controlled pivotal study for the treatment option for children with achondroplasia; and BBP-631, an AAV5 gene transfer product candidate that is in Phase 1/2 clinical trial for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD. The company also develops Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, which is in phase 3 clinical trial for treating autosomal dominant hypocalcemia type 1, or ADH1; and BBP-418, a glycosylation substrate pro-drug that is in Phase 3 clinical trial for treating limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9). In addition, it engages in developing products for mendelian, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; and Leidos Biomedical Research, Inc. The company was founded in 2015 and is headquartered in Palo Alto, California.
Read More on BridgeBio Pharma

Today's Range

Now: $68.54
Low: $68.00
High: $72.35

50 Day Range

MA: $72.53
Low: $63.73
High: $79.91

52 Week Range

Now: $68.54
Low: $28.33
High: $84.94

Volume

2,906,372 shs

Average Volume

2,697,859 shs

Market Capitalization

$13.29 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13

Who are the company insiders with the largest holdings of BridgeBio Pharma?

BridgeBio Pharma's top insider investors include:
  1. Genetic Disorder LP Kkr (Major Shareholder)
  2. Global Investors Lp Viking (Major Shareholder)
  3. Neil Kumar (CEO)
  4. Charles J Homcy (Director)
  5. Frank Mccormick (Director)
  6. Thomas Trimarchi (CFO)
  7. Maricel Apuli (CAO)
  8. Andrew Lo (Director)
  9. Brian C Stephenson (CFO)
  10. Andrea Ellis (Director)
  11. Ronald J Daniels (Director)
  12. Randal W Scott (Director)
  13. Hannah Valantine (Director)
Learn More about top insider investors at BridgeBio Pharma.

Who are the major institutional investors of BridgeBio Pharma?

BridgeBio Pharma's top institutional investors include:
  1. Vanguard Group Inc. — 8.75%
  2. Viking Global Investors LP — 7.47%
  3. Janus Henderson Group PLC — 5.71%
  4. Farallon Capital Management LLC — 4.67%
  5. Invesco Ltd. — 2.51%
  6. Geode Capital Management LLC — 2.29%
Learn More about top institutional investors of BridgeBio Pharma stock.

Which institutional investors are selling BridgeBio Pharma stock?

Within the previous quarter, BBIO stock was sold by these institutional investors:
  1. Viking Global Investors LP
  2. Man Group plc
  3. Deutsche Bank AG
  4. Royal Bank of Canada
  5. Adage Capital Partners GP L.L.C.
  6. Frazier Life Sciences Management L.P.
  7. Boone Capital Management LLC
  8. Prosight Management LP
Within the previous year, company insiders that have sold BridgeBio Pharma company stock include:
  1. Genetic Disorder LP Kkr (Major Shareholder)
  2. Global Investors Lp Viking (Major Shareholder)
  3. Neil Kumar (CEO)
  4. Charles J Homcy (Director)
  5. Frank Mccormick (Director)
  6. Thomas Trimarchi (CFO)
  7. Maricel Apuli (CAO)
  8. Andrew Lo (Director)
  9. Brian C Stephenson (CFO)
  10. Andrea Ellis (Director)
  11. Ronald J Daniels (Director)
  12. Randal W Scott (Director)
Learn More investors selling BridgeBio Pharma stock.

Which institutional investors are buying BridgeBio Pharma stock?

During the last quarter, BBIO stock was purchased by institutional investors including:
  1. Brooklands Fund Management Ltd
  2. Price T Rowe Associates Inc. MD
  3. Janus Henderson Group PLC
  4. Norges Bank
  5. Wellington Management Group LLP
  6. Allspring Global Investments Holdings LLC
  7. Invesco Ltd.
  8. Farallon Capital Management LLC